Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 1/2013

01-03-2013 | Case Report

Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus

Authors: Liza Rajasekhar, Shabina Habibi, Pushpalatha Sudhakar, Narsimulu Gumdal

Published in: Clinical Rheumatology | Special Issue 1/2013

Login to get access

Abstract

Systemic lupus erythematosus (SLE) is a multisystem disease of autoimmune origin. Lymphedema is a very uncommon entity and has not been previously documented in SLE. We report lymphatic obstruction involving all four limbs as a cause of extremity edema in a patient with SLE.
Literature
1.
Gunaydin I et al (1999) Lower limb pitting edema in systemic lupus erythematosus. Rheumatol Int 18(4):159–160PubMedCrossRef
2.
Pittau E et al (1998) Systemic lupus erythematosus with pitting oedema of the distal lower limbs. Br J Rheumatol 37(1):104–105PubMedCrossRef
3.
Pittau E, Passiu G, Mathieu A (2000) Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging. Joint Bone Spine 67(6):544–549PubMedCrossRef
4.
Yamanishi Y et al (1993) Two cases of RA-like and SLE-like features similar to remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome). Ryumachi 33(2):162–168PubMed
5.
Alpigiani MG et al (2008) Remitting symmetrical pitting edema of hands and feet at onset of pediatric systemic lupus erythematosus: a case report. Clin Exp Rheumatol 26(6):1166PubMed
6.
Kiely PD, Mortimer PS, Bourke BE (1996) Lymphatic function in inflammatory arthritis. Br J Rheumatol 35(4):396PubMedCrossRef
7.
McRorie ER et al (1995) Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol 34(7):689–691PubMedCrossRef
Metadata
Title
Lymphatic obstruction as a cause of extremity edema in systemic lupus erythematosus
Authors
Liza Rajasekhar
Shabina Habibi
Pushpalatha Sudhakar
Narsimulu Gumdal
Publication date
01-03-2013
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue Special Issue 1/2013
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1268-y

Other articles of this Special Issue 1/2013

Clinical Rheumatology 1/2013 Go to the issue

Case Report

Case report. Elbow monoarthritis revealing B cell non-Hodgkin’s lymphoma

Case Report

Case report: acute thrombotic occlusion and pseudoaneurysm of the brachial artery diagnosed by Doppler ultrasound after nondiagnostic angiography

Case Report

A sarcoidosis patient with hand involvement and large pulmonary lymph nodes: results of 1-year treatment with methotrexate

Case Report

Successful treatment of aortic root dilatation in a patient with relapsing polychondritis

Case Report

Listeria monocytogenes infection in patients with systemic lupus erythematosus

Case Report

Hormonal therapy in a patient with ovarian agenesis and possible SLE: a choice to be made
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits